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ABSTRACT 
Objective: To extend a previously published checklist of study design features to include study 
designs often used by health systems researchers and economists. The intention is to help review 
authors in any field to set eligibility criteria for studies to include in a systematic review that relate 
directly to the intrinsic strength of the studies in inferring causality. It also seeks to clarify key 
equivalences and differences in terminology used by different research communities.  
 
Study design and setting: expert consensus meeting. 
 
Results: The checklist comprises seven questions, each with a list of response items, addressing: 
clustering of an intervention as an aspect of allocation or due to the intrinsic nature of the delivery 
of the intervention; for whom, and when, outcome data are available; how the intervention effect 
was estimated; the principle underlying control for confounding; how groups were formed; the 
features of a study carried out after it was designed; the variables measured before intervention.  
 
Conclusion: The checklist clarifies the basis of credible quasi-experimental studies, reconciling 
different terminology used in different fields of investigation and facilitating communications 
across research communities. By applying the checklist, review authors’ attention is also directed to 
the assumptions underpinning the methods for inferring causality. 
 
Word count: 200 
Key words: health care; health system; evaluation; study design; quasi-experimental; non-
randomized 
Running title: Classifying effectiveness studies based on design features. 
  
Introduction 
 
There are difficulties in drawing up a taxonomy of study designs to evaluate health care 
interventions or systems that do not use randomization [1].  To avoid the ambiguities of study 
design labels, a checklist of design features has been proposed by the Cochrane Non-Randomized 
Studies Methods Group (including BCR and GAW) to classify non-randomized studies of health 
care interventions on the basis of what researchers did [1,2].  The checklist includes items about: 
whether a study made a comparison and, if yes, how comparison groups were formed; the timing of 
key elements of a study in relation to its conduct; and variables compared between intervention and 
comparator groups [1,2]. The checklist was created primary from the perspective of health care 
evaluation, i.e. the kinds of intervention most commonly considered in Cochrane reviews of 
interventions. 
 
The checklist works well in principle for study designs in which the allocation mechanism applies 
to individual participants, although it does not characterise unit of analysis issues that may arise 
from the mechanism of allocation or the organisational hierarchy through which an intervention is 
provided (clustering by practitioner or organisational unit on which allocation is based).  Most 
health interventions are delivered by discrete care provider units, typically organised hierarchically 
(e.g. hospitals, family practices, practitioners); this makes clustering important, except when 
allocation is randomised, because interventions are chosen by care provider units in complex ways.  
A modified checklist was also suggested for cluster-allocated designs (diverse study designs in 
which the allocation mechanism applies to groups of participants) [1,2], often used to evaluate 
interventions applied at the level of the group (e.g. disease prevention, health education, health 
policy), but the authors acknowledged that this checklist had not been well piloted.  
 
There are three key challenges when trying to communicate study designs that do not use 
randomization to evaluate the effectiveness of interventions. First, study design labels are diverse or 
ambiguous, especially for cluster-allocated designs; moreover, there are key differences between 
research fields in the way that similar designs are conceived.  Second, some study designs are, in 
fact, strategies for analysis rather than designs per se.  Terms such as quasi-experimental, natural 
experiment and observational cause particular ambiguity. The current checklist does not explicitly 
consider designs /analyses commonly used in health systems research (including so-called “credible 
quasi-experimental studies” [3,4]), often taking advantage of large administrative or other available 
datasets, and in other cases using data purposely collected as part of prospective designs where 
random assignment is not feasible.  Importantly, differences of opinion exist between health care 
and health systems researchers about the extent to which some studies are “as good as” randomized 
trials when well conducted; it is not clear whether this is because common designs are described 
with different labels or whether there are substantive differences.  Therefore, our primary aim in 
this paper is revise the checklist to overcome these limitations.  
 
Specific objectives were: (a) to include a question to capture information about clustering; (b) to 
extend the checklist to include study designs often used by health systems researchers and 
economists in a way that deals with the design/analysis challenge.  We intended that the revised 
checklist should be able to resolve the differences in opinion about the extent to causality can be 
inferred from non-randomized studies with different design features, improving communication 
between different health research communities. We do not intend that the checklist should be used 
as a tool to assess risk of bias, which can vary across studies with the same design features; we 
recommended that the risk of bias is assessed separately, with an appropriate tool. 
 
The paper is structured in three parts. Part 1 sets out designs currently used for health systems 
evaluations, illustrating their use through inclusion of the different designs in a recent systematic 
review. Part 2 describes designs used for health intervention/programme evaluations. Part 3 clarifies 
some of the ambiguities of study design labels using the proposed design feature framework. 
 
Part 1: “Quasi-experimental” studies considered by health system researchers and health 
economists 
 
Health systems researchers and health economists use a wide range of ‘quasi-experimental’ 
approaches to estimate causal effects of health care interventions. Some methods are considered 
stronger than others in estimating an unbiased causal relationship. ‘Credible quasi-experimental 
studies’ are ones that ‘estimates a causal effect using exogenous variation in the exposure of interest 
which is not directly controlled by the researcher’.  This exogenous variation refers to variation 
determined outside the system of relationships that are of interest, and in some situations may be 
considered ‘as good as random’ variation [3,4]. Credible quasi-experimental methods are by 
definition based on ‘allocation’ that is not controlled by the investigators and the term can be 
applied to different assignment rules; most allocation rules are not randomized but some are based 
on identifying a source of variation in an exposure of interest that is assumed to be random (or 
exogenous). In the present context, they are considered to use rigorous designs and methods of 
analysis which can enable studies to adjust for unobservable sources of confounding [5] and are 
identical to the union of ‘strong’ and ‘weak’ quasi-experiments as defined by Rockers et al. [4].  
 
Credible quasi-experimental methods use assignment rules which are either known or can be 
modelled statistically, including: methods based on a threshold on a continuous scale (or ordinal 
scale with a minimum number of units) such as a test score (regression discontinuity design 
(RDD)); or another form of ‘exogenous variation’ arising, for example, due to geographical or 
administrative boundaries (natural experiments).  Quasi-experimental methods are also applied 
when assignment is self-selected by programme administrators or by beneficiaries themselves [6,7].  
Credible methods commonly used to identify causation among self-selected groups include 
instrumental variables estimation (IVE), difference studies (including difference-in-differences, 
DIDs) and, to a lesser extent, propensity score matching (PSM) where individuals or groups are 
matched on pre-existing characteristics measured at baseline and interrupted time series (ITS).  
 
Quasi-experimental methods are used increasingly to evaluate programmes in health systems 
research.  Gaarder and colleagues [8], Baird and colleagues [9] and Kabeer and Waddington [10] 
have published reviews incorporating quasi-experimental studies on conditional cash transfer (CCT) 
programmes, which make welfare benefits conditional upon beneficiaries taking specified actions 
like attending a health facility during the pre-/post-natal period or enrolling children in school. 
Other reviews including quasi-experimental studies have evaluated health insurance schemes 
[11,12] and maternal and child health programmes [13]. We use studies from the review on the 
effects of CCT programmes to illustrate the wide range of quasi-experimental methods used to 
quantify causal effects of the programmes (Table 1).  
 
Some of the earliest CCT programmes randomly assigned clusters (households) and used 
longitudinal household survey data collected by researchers to estimate the effects of CCTs on the 
health of both adults and children [14].  The design and analysis of a cluster randomized controlled 
trial of this kind is familiar to health care researchers [15]. 
 
In other cases it was not possible to assign beneficiaries randomly. In Jamaica’s PATH programme 
[16], benefits were allocated to people with scores below a criterion level on a multi-dimensional 
deprivation index and the effects of the programme were estimated using a regression discontinuity 
analysis.  This study involved recruiting a cohort of participants being considered for benefits, to 
whom a policy decision was applied (i.e. assign benefits or not on the basis the specified 
deprivation threshold).  In such studies, by assigning the intervention on the basis of a cut-off value 
for a covariate, the assignment mechanism (usually correlated with the outcome of interest) is 
completely known and can provide a strong basis for inferences, although usually in a less efficient 
manner than in RCTs. The treatment effect is estimated as the difference (‘discontinuity’) between 
two predictions of the outcome based on the covariate (the average treatment effect at the cut-off, or 
ATEC), one for individuals just above the covariate cut-off (control group) and one for individuals 
just below the cut-off (intervention group) [17].  The covariate is often a test score (e.g. to decide 
who receives a health or education intervention) [18] but can also be distance from a geographic 
boundary [19]. Challenges of this design are assignment determined approximately, but not 
perfectly, by the cut-off [20] or circumstances in which participants may be able to control factors 
determining their assignment status such as their location. 
 
As with health care evaluation, many studies in health systems research combine multiple methods. 
In Ecuador’s Bono de Desarrollo Humano (BDH) programme, leakages in implementation caused 
ineligible families to receive the programme, compromising the original discontinuity assignment. 
To compensate for this problem, the effects of the programme were estimated as a ‘fuzzy 
discontinuity’ using IVE [21].  An instrument (in this case, a dichotomous variable taking the value 
of 1 or 0 depending on whether the participating family had a value on a proxy means test below or 
above a cut-off value used to determine eligibility to the programme) must be associated with the 
assignment of interest, unrelated to potential confounding factors and related to the outcome of 
interest only by virtue of the relationship with the assignment of interest (and not, for example, 
eligibility to another programme which may affect the outcome of interest).  If these conditions 
hold, then an unbiased effect of assignment can be estimated using two-stage regression methods 
[22].  The challenge lies not in the analysis itself (although such analyses are, typically, inefficient) 
but in demonstrating that the conditions for having a good instrument are met. 
 
In the case of Bolsa Alimentação in Brazil, a computer error led eligible participants whose names 
contained non-standard alphabetical characters to be excluded from the programme. Since there are 
no reasons to believe that these individuals would have had systematically different characteristics 
to others, the exclusion of individuals was considered ‘as good as random’ (i.e. a quasi-RCT).  
Again, the effects were estimated using an instrumental variable analysis [23]. 
 
Comparatively few studies in this review used interrupted time-series (ITS) estimation, and we are 
not aware of any studies in this literature which have been able to draw on sufficiently long time-
series with longitudinal data for individual units of observation in order for the design to qualify “as 
good as randomized”.  An evaluation of Nepal’s Safe Delivery Incentive Programme (SDIP) drew 
on multiple cohorts of eligible households before and after implementation over a seven-year period 
[24].  The outcome (neonatal mortality) for each household was available at points in time that 
could be related to the inception of the programme. Unfortunately, comparison group data were not 
available for non-participants, so an analysis of secular trends due to general improvements in 
maternal and child health care (i.e. not due to SDIP) was not possible. However, the authors were 
able to implement a regression ‘placebo test’, in which SDIP treatment was linked to an outcome 
(use of antenatal care) which was not expected to be affected by the programme, the rationale being 
that the lack of an estimated spike in antenatal care at the time of the expected change in mortality 
might suggest that these other confounding factors were not at play. But ultimately, due to the lack 
of comparison group data, the authors themselves note that the study is only able to provide 
‘plausible evidence of an impact’ rather than probabilistic evidence (p. 224). 
 
Individual-level difference-in-difference (DID) analyses use participant-level panel data (i.e. 
information collected in a consistent manner over time for a defined cohort of individuals).  The 
Familias en Accion programme in Colombia was evaluated using a DID analysis, where eligible 
and ineligible administrative clusters were matched initially using propensity scores.  The effect of 
the intervention was estimated as the difference between groups of clusters that were or were not 
eligible for the intervention, taking into account the propensity scores on which they were matched 
[25].  DID analysis is only a credible method when we expect unobservable factors which 
determine outcomes to affect both groups equally over time (the ‘common trends’ assumption).  In 
the absence of common trends across groups, it is not possible to attribute the growth in the 
outcome to the programme using the DID analysis.  The problem is that we rarely have multiple 
period baseline data in order to compare variation between groups in outcomes over time before 
implementation, so the assumption is not verifiable.  In such cases, placebo tests on outcomes which 
are related to possible confounders, but not the programme of interest, can be investigated (see also 
above).  Where multiple period baseline data are available, it may be possible to test for common 
trends directly and, where common trends in outcome levels are not supported, undertake a 
‘difference-in-difference-in-differences’ (DDD) analysis.  In Cambodia, the evaluators used DDD 
analysis to evaluate the Cambodia Education Sector Support Project (CESSP), overcoming the 
observed lack of common trends in pre-programme outcomes between beneficiaries and non-
beneficiaries [26].  
 
As in the case of Attanasio et al. above [25], difference studies are usually made more credible 
when combined with methods of statistical matching, since such studies are restricted to (or 
weighted by) individuals and groups with similar probabilities of participation based on observed 
characteristics – that is, observations “in the region of common support”.  However, where panel or 
multiple time-series cohort data are not available, statistical matching methods are often used alone.  
By contrast with the above examples, a conventional cohort study design was used to evaluate 
Tekoporã in Paraguay, relying on propensity score matching and propensity weighted regression 
analysis of beneficiaries and non-beneficiaries at entry into the cohort to control for confounding 
[27].  Similarly, for Bolsa Familia in Brazil evaluators applied propensity score matching to cross-
sectional (census) data [28].  Variables used to match observations in treatment and comparison 
should not be determined by programme participation and are best collected at baseline.  However, 
this type of analysis alone does not satisfy the criterion of enabling adjustment for unobservable 
sources of confounding because it cannot rule out confounding of health outcomes data by 
unmeasured confounding factors, even when participants are well characterised at baseline. 
 
 
Box 1: Thumbnail sketches of quasi-experimental study designs used by health system 
researchers 
 
Randomized 
controlled trial 
(RCT) 
Individual participants, or clusters of participants, are randomly allocated 
to intervention or comparator. 
 
Quasi-
randomized 
controlled trial 
(Q-RCT) 
Individual participants, or clusters of participants, are allocated to 
intervention or comparator in a quasi-random manner.  For a credible 
study, the allocation mechanism should not be known to participants or 
any personnel responsible for data collection.  
The term natural experiment [4] is used instead when a study takes 
advantage of an ‘exogenous assignment’ mechanism such as an error in 
implementation (as in the case of Morris et al. [23]), rather than explicit 
allocation by an experimenter or other decision maker who may be able to 
bias decisions about recruitment / participation. 
Instrumental 
variables 
estimation (IVE) 
Analysis of a cohort using an instrumental variable (IV) to estimate the 
effect of an intervention compared to a comparator in ‘two-stage’ analysis.  
Requirements for a “good” IV are: (i) IV is strongly associated with 
allocation; (ii) IV is independent of confounders between intervention and 
outcome; and (iii) IV is independent of the outcome, given the allocation 
and confounders between allocation and the outcome [22]. 
Regression 
discontinuity 
(RD) 
Analysis of a cohort which exploits local variation around a cut-off on a 
continuous ‘forcing’ variable used by decision-makers to determine 
allocation. A “good” forcing variable is: (i) strongly associated with 
allocation; (ii) independent of confounders between intervention and 
outcome; and (iii) independent of the outcome at the bandwidth around the 
cut-off. 
Interrupted time 
series (ITS) 
Analysis of a cohort with longitudinal ‘panel’ datasets measured at the 
disaggregate level (i.e., the same people measured multiple times before 
and after treatment) [4]. It is also common for longitudinal datasets to be 
clustered at aggregate levels of care (e.g., the health facility or district). In 
such cases, confounding by secular trends needs to be assessed, for 
example with reference to a contemporaneous comparison group 
(controlled interrupted time-series) and an assessment of performance bias 
– and some of the entries in the corresponding column would change. 
Controlled 
interrupted time 
series (CITS) 
As above for an interrupted time series but with data for a 
contemporaneous cohort with longitudinal ‘panel’ dataset for participants 
for whom the intervention is not implemented. 
Difference study, 
including 
difference in 
differences study 
(DID) 
Analysis of a cohort over time, in which no individuals have the 
intervention at the start and some receive the intervention by the end of the 
period of study. The typical study is clustered, with some clusters 
implementing the intervention; data are often also aggregated by cluster, 
e.g. primary care practice. A “good” difference study is able to verify 
‘common trends’ and enables adjustment for probability of participation 
across groups (common support). A key feature of this design is the 
availability of longitudinal data for the same individuals for the entire 
period of study; studies that evaluate cluster-aggregated data often ignore 
changes in the individuals belonging to a cluster over time. 
Cross sectional 
study (XS) 
The feature of this study design is that data required to classify individuals 
according to receipt of the intervention or comparator of interest and 
according to outcome are collected at the same time. Common methods of 
analysis include statistical matching (e.g. PSM) and adjusted regression 
analysis. A key limitation of this design is the inability to account for 
unobservable confounding, and in some instances reverse-causality.  
 
 
Part 2: “quasi-experimental” designs used by health care evaluation researchers 
 
The term ‘quasi-experimental’ is also used by health care evaluation and social science researchers 
to describe studies in which assignment is non-random and influenced by the researchers.  At first 
appearance, many of the designs seem similar, although they are often labelled differently.  
Although an assignment rule may be known, it may not be exploitable in the way described above 
for health system evaluations; for example quasi-random allocation may be biased because of a lack 
of concealment, even when the allocation rule is “as good as random”.   
 
Researchers also use more conventional epidemiological designs, sometimes called observational, 
that exploit naturally occurring variation.  Sometimes, the effects of interventions can be estimated 
in these cohorts using instrumental variables [prescribing preference; surgical volume; geographic 
variation, distance from health care facility], quantifying the effects of an intervention in a way that 
is considered to be unbiased [29-31].  Instrumental variable estimation using data from a 
randomized controlled trial to estimate the effect of treatment in the treated, when there is 
substantial non-adherence to the allocated intervention, is a particular instance of this approach 
[32,33].   
 
Non-randomized study design labels commonly used by health care evaluation researchers include: 
non-randomized controlled trial (NRCT), controlled before-and-after study (CBA), interrupted-
time-series study (ITS; and CITS), historically controlled study (HCT), cohort study (CS), nested 
case-control study (NCC), case-control study (CC), cross-sectional study (XS) and before-after 
study (BA). Thumbnail sketches of these study designs are given in Box 2.  In addition, researchers 
sometimes report findings for uncontrolled cohorts or individuals (“case” series or reports), which 
only describe outcomes after an intervention [34]; these are not considered further because these 
studies do not collect data for an explicit comparator.  It should be noted that these sketches are the 
authors’ interpretations of the labels; studies that other researchers describe using these labels may 
not conform to these descriptions.  
 
The designs can have diverse features, despite having the same label. Particular features are often 
chosen to address the logistical challenges of evaluating particular research questions and settings. 
Therefore, it is not possible to illustrate them with examples drawn from a single review as in Part 
1; instead, studies exemplifying each design are cited across a wide range of research questions and 
settings. The converse also occurs, i.e. study design labels are often inconsistently applied. This can 
present great difficulties when trying to classify studies, for example to describe eligibility for 
inclusion in a review.  Relying on the study design labels used by primary researchers themselves to 
describe their studies can lead to serious misclassifications. 
 
For some generic study designs, there are distinct study types.  For example, a cohort study can 
study intervention and comparator groups concurrently, with information about the intervention and 
comparator collected prospectively (PCS) or retrospectively (RCS), or study one group 
retrospectively and the other group prospectively (HCS).  These different kinds of cohort study are 
conventionally distinguished according to the time when intervention and comparator groups are 
formed, in relation to the conception of the study.  Some studies are sometimes incorrectly termed 
PCS, in our view, when data are collected prospectively, e.g. for a clinical database, but when 
definitions of intervention and comparator required for the evaluation are applied retrospectively; in 
our view, this should be a RCS. 
 
 
Box 2: Thumbnail sketches of quasi-experimental study designs used by health care 
evaluation researchers.  
Studies are cited which correspond to the way in which we conceive studies described with these 
labels. 
 
Randomized 
controlled trial 
(RCT) 
Individual participants, or clusters of participants, are randomly allocated to 
intervention or comparator. This design is the same as the RCT design 
described in Box 1. 
 
Quasi-randomized 
controlled trial (Q-
RCT) 
Individual participants, or clusters of participants, are allocated to 
intervention or comparator in a quasi-random manner.  In health care 
evaluation studies, the allocation rule is often by alternation, day of the 
week, odd/even hospital or social security number [35]. The allocation rule 
may be as good as random but, typically, gives rise to a less credible study 
(compared to health system studies, where the allocation rule is applied by a 
higher level decision maker); if allocation is not concealed, research 
personnel who know the rule can recruit selectively or allocate participants 
in a biased way. This design has essentially the same as the Q-RCT design 
described in Box 1 but with different mechanisms for allocation. 
Controlled before 
and after study 
(CBA) 
Study in which outcomes are assessed at two time periods for several 
clusters (usually geographic). Clusters are classified into intervention and 
comparator groups. All clusters are studied without the intervention during 
period 1. Between period 1 and 2, clusters in the intervention group 
implement the intervention of interest while clusters in the comparator group 
do not. The outcome for clusters receiving the intervention is compared to 
the outcome for comparator clusters during period 2, adjusted for the 
outcomes observed during period 1 (when no clusters had had the 
intervention).  Observations usually represent episodes of care, so may or 
may not correspond to the same individuals during the two time periods.  
Data at either an aggregate [36] or individual level [37] can be analysed. This 
design has similarities to the DID design described in Box 1. 
Non-randomized 
controlled trial 
(NRCT) 
This is usually a prospective cohort study in which allocation to intervention 
and comparator is not random or quasi-random and is applied by research 
personnel [38]. The involvement of research personnel in the allocation rule 
may be difficult to discern; such studies may be labelled observational if the 
personnel responsible for the allocation rule are not clearly described or 
some personnel have both health care decision making and researcher roles. 
Individual-level data are usually analysed. Note that non-random allocation 
of a health care intervention is often defined in relation to organisational 
factors (ward, clinic, doctor, provider organization) [39], and the analysis 
should take account of the data hierarchy if one exists. 
Interrupted time 
series (ITS) 
When used to study health care interventions, observations usually represent 
episodes of care or events, the cohorts studied may or may not correspond to 
the same individuals at different time points and are often clustered in 
organisational units (e.g. a health facility or district). (Such studies may be 
considered to consist of multiple cross-sectional ‘snapshots’.) The analysis 
may be aggregated at the level of the clusters [40] or at the level of 
individual episodes of care [41]. If ITS do not have the benefit of analysing 
multiple measurements from the same cohort over time (Box 1), 
confounding by secular trends needs to be assessed, for example with 
reference to a contemporaneous comparison group (controlled interrupted 
time-series, CITS, below). NB. Entries in Table 2 are for ITS as defined in 
Box 1; for ITS as defined here, entries for some cells would change. This 
design is similar to the ITS design described in Box 1. 
Controlled 
interrupted time 
series (CITS) 
As above for an ITS but with data for a contemporaneous comparison group 
in which the intervention was not implemented [42]. Measurements for the 
comparison group should be collected using the same methods. This design 
is similar to the CITS design described in Box 1. 
Concurrently 
controlled 
A cohort study in which subjects are identified prospectively and classified 
as having received the intervention or comparator of interest on the basis of 
prospective cohort 
study (PCS) 
the prospectively collected information [43].  Data for individuals are usually 
analysed.  However, it is important to note that non-random receipt of a 
health care intervention is almost always defined in relation to organisational 
factors (ward, clinic, doctor, provider organization), and the analysis should 
take into account the data hierarchy. 
Concurrently 
controlled 
retrospective 
cohort study (RCS) 
A cohort study in which subjects are identified from historic records and 
classified as having received the intervention or comparator of interest on the 
basis of the historic information [44].  As for a PCS, data for individuals are 
usually analysed but the analysis should take account of the data hierarchy.  
Historically 
controlled cohort 
study (RCS) 
This type of cohort study is a combination of a RCS (for one group, usually 
receiving the comparator) and a PCS (for the second group, usually receiving 
the intervention) [45].  Thus, the comparison between groups is not 
contemporaneous. The analysis should take into account the data hierarchy. 
Case control study 
(CC) 
Consecutive individuals experiencing an outcome of interest are identified, 
preferably prospectively, from within a defined population (but for whom 
relevant data have not been collected) and form a group of ‘cases’ [46]. 
Individuals, sometimes matched to the cases, who did not experience the 
outcome of interest are also identified from within the defined population 
and form the group of ‘controls.’  Data characterising the intervention or 
comparator received in the past are collected retrospectively from existing 
records or by interviewing participants.  The receipt of the intervention or 
comparator of interest is compared among cases and controls.  If applicable, 
the analysis should take into account the data hierarchy. 
Nested case control 
study (NCC) 
Individuals experiencing an outcome of interest are identified from within a 
defined cohort (for which some data have already been collected) and form a 
group of ‘cases.’  Individuals, often matched to the cases, who did not 
experience the outcome of interest are also identified from within the defined 
cohort and form the group of ‘controls’ [47].  Additional data required for 
the study, characterising the intervention or comparator received in the past, 
are collected retrospectively from existing records or by interviewing 
participants.  The receipt of the intervention or comparator of interest is 
compared among cases and controls.  If applicable, the analysis should take 
into account the data hierarchy. 
Before after study 
(BA) 
As for CBA but without data for a control group of clusters [48].  An 
uncontrolled comparison is made between frequencies of outcomes for the 
two time points.  
This term may also be applied to a study in which a cohort of individuals 
have the outcome (e.g. function, symptoms or quality of life) measured 
before an intervention and after the intervention [49]. This type of study 
comprises a single “exposed” cohort [34], with the outcome measured before 
and after exposure If applicable, the analysis should take into account the 
data hierarchy.  
Cross sectional 
study (XS) 
The feature of this study design is that information required to classify 
individuals according to receipt of the intervention or comparator of interest 
and according to outcome are collected at the same time, sometimes 
preventing researchers from knowing whether the intervention preceded the 
outcome [50]. In cross-sectional studies of health interventions, despite 
collecting data about the intervention/comparator and outcome at one point 
in time, the nature of the intervention and outcome may allow one to be 
confident about whether the intervention preceded the outcome. This design 
is similar to the XS design described in Box 1. 
 Part 3: Study design features and their role in disambiguating study design labels 
 
Some of the study designs described in Parts 1 and 2 may seem similar, e.g. DID and CBA, 
although they are labelled differently.  Some other study design labels, e.g. CITS/ITS, are used by 
both types of researcher.  In our view, these labels obscure some of the detailed features of the study 
designs that affect the robustness of causal attribution.  Therefore, we have extended the checklist 
of features to highlight these differences.  In these instances where researchers use the same label to 
describe studies with subtly different features, we do not intend to imply that one or other use is 
incorrect; we merely wish to point out that studies referred to by the same labels may differ in ways 
that affect the robustness of an inference about the causal effect of the intervention of interest. 
 
The checklist now includes seven questions (Table 2).  The table also sets out our responses for the 
range of study designs as described in Boxes 1 and 2.  The response “possibly” (P) is prevalent in 
the table, even given the descriptions in these boxes. We regard this as evidence of the ambiguity / 
inadequate specificity of the study design labels. 
 
Question 1 is new and addresses the issue of clustering, either by design or through the 
organizational structure responsible for delivering the intervention (Box 3). This question avoids the 
need for separate checklists for designs based on assigning individual and clusters. A “yes” 
response can be given to more than one response item; the different types of clustering may both 
occur in a single study and implicit clustering can occur an individually allocated study. 
 
Box 3: Clustering in studies evaluating the effects of health system or health care 
interventions 
 
Clustering is a potentially important consideration, in both RCTs and non-randomized studies. 
Clusters exist when observations are nested within higher level organizational units, or structure 
for implementing an intervention; typically, observations within clusters will be more similar with 
respect to outcomes of interest than observations between clusters.  Clustering is a natural 
consequence of many methods of non-randomized assignment/designation because of the way in 
which many interventions are implemented. Analyses of clustered data that do not take clustering 
into account will tend to overestimate the precision of effect estimates. 
 
Clustering occurs when implementation of an intervention is explicitly at the level of a cluster / 
organisational unit (as in a cluster-randomized controlled trial, in which each cluster is explicitly 
allocated to control or intervention). Clustering can also arise implicitly, from naturally occurring 
hierarchies in the dataset being analysed, that reflect clusters that are intrinsically involved in the 
delivery of the intervention or comparator. Both explicit and implicit clustering can be present in a 
single study. 
 
Examples of types of cluster 
• Practitioner (surgeon; therapist, family doctor; teacher; social worker; probation officer; etc.). 
• Organisational unit (general practice, hospital [ward], community care team; school, etc.). 
• Social unit (family unit; network of individuals clustered in some non-geographic network, 
etc.). 
• Geographic area (health region; city jurisdiction; small electoral district, etc.). 
 
‘Explicit’ clustering 
• Clustering arising from allocation / formation of groups; clusters can contain only intervention 
or control observations. 
 ‘Implicit’ clustering 
• Clustering arising from naturally occurring hierarchies in the dataset being analysed to answer 
the research question. 
• Clusters can contain intervention and control observations in varying proportions.  
• Factors associated with designation as intervention or control may vary by cluster. 
 
No clustering 
• Designation of an observation as intervention or control is only influenced by the characteristics 
of the observation (e.g. patient choice to self-medicate with an over-the-counter medication; 
natural experiment in which allocation of individuals is effectively random, as in the case of 
Bolsa Alimentação where a computer error led to the allocation to intervention or comparator 
[23].) 
 
Question 1 in the checklist distinguishes individual allocation, cluster allocation (explicit 
clustering), and clusters due to the organizational hierarchy involved in the delivery of the 
interventions being compared (implicit clustering).  Users should respond factually, i.e. with 
respect to the presence of clustering, without making a judgement about the likely importance of 
clustering (degree of dependence between observations within clusters).  
 
 
Questions 2-4 are also new, replacing the first question (“Was there a relevant comparison?”) in the 
original checklist [1,2].  These questions are designed to tease apart the nature of the research 
question and the basis for inferring causality.  
 
Question 2 classifies studies according to the number of times outcomes assessments were 
available.  In each case, the response items distinguish whether or not the outcome is assessed in the 
same or different individuals at different times. Only one response item can be answered “yes”. 
 
Treatment effects can be estimated as changes over time or between groups.  Question 3 aims to 
classify studies according to the parameter being estimated.  Response items distinguish changes 
over time for the same or different individuals.  Only one response item can be answered “yes”. 
 
Question 4 asks about the principle through which the primary researchers aimed to control for 
confounding. Three response items distinguish methods that:  
a. control in principle for any confounding in the design, i.e. by randomization, IVE, or 
regression discontinuity;  
b. control in principle for time invariant unobserved confounding, i.e. by comparing 
differences in outcome from baseline to end-of-study, again using longitudinal/panel data 
for a constant cohort; or 
c. control for confounding by known and observed covariates (either by estimating treatment 
effects in ‘adjusted’ statistical analyses or in the study design by restricting enrollment, 
matching and/or stratified sampling on known and observed covariates).  
The choice between these items (again, only one can be answered “yes”) is key to understanding the 
basis for inferring causality. 
 
Question 5-7 are essentially the same as in the original checklist [1,2]. Question 5 asks about how 
groups (of individuals or clusters) were formed, since treatment effects are most frequently 
estimated from between group comparisons.  An additional response option, namely by a forcing 
variable, has been included to identify credible quasi-experimental studies that use an explicit rule 
for assignment based on a threshold for a variable measured on a continuous or ordinal scale or in 
relation to a spatial boundary.  When answering “yes” to this item, the review author should also 
identify the nature of the variable by answering “yes” to another item.  Possible assignment rules 
are identified: the action of researchers, time differences, location differences, healthcare decision 
makers / practitioners, policy makers, on the basis of the outcome or some other process.  Other, 
non-experimental, study designs should be classified by the method of assignment (same list of 
variables) but without there being an explicit assignment rule. 
 
Question 6 asks about important features of a study in relation to the timing of their 
implementation.  Studies are classified according to whether three key steps were carried out after 
the study was designed, namely: acquisition of source data to characterise individuals / clusters 
before intervention; actions or choices leading to an individual or cluster becoming a member of a 
group; and the assessment of outcomes.  One or more of these items can be answered “yes”, as 
would be the case in a conventional RCT.  
 
Question 7 asks about the variables that were measured and available to control for confounding in 
the analysis.  The two broad classes of variables that are important are: the identification and 
collection of potential confounder variables; baseline assessment of the outcome variable(s).  The 
answers to this question will be less important if the researchers of the original study used a method 
to control for any confounding, i.e. used a credible quasi-experimental design.  
 
The health care evaluation community has historically been much more difficult to win around to 
the potential value of non-randomized studies to evaluate interventions. We think that the checklist 
helps to explain why, i.e. because designs used in health care evaluation do not often control for 
unobservables when the study features are examined carefully. To the extent that these features are 
immutable, the scepticism is justified. However, to the extent that studies may be possible with 
features that promote the credibility of causal inference, health care evaluation researchers may be 
missing an opportunity to provide high quality evidence. 
 
Reflecting on the circumstances of non-randomized evaluations of health care and health system 
interventions may provide some insights why these different groups have disagreed about the 
credibility of effects estimated in quasi-experimental studies.  The checklist shows that credible 
quasi-experimental studies gain credibility from using high quality longitudinal / panel data; such 
data characterising health care are rare, leading to evaluations that ‘make do’ with the data that are 
available in existing information systems.  
 
The risk of confounding in health care settings is inherently greater because participants’ 
characteristics are fundamental to choices about interventions in usual care; mitigating against this 
risk requires high quality clinical data to characterise participants at baseline and, for pharmaco-
epidemiological studies about safety, often over time.  Important questions about health care for 
which quasi-experimental methods of evaluation are typically considered are often to do with the 
outcome of providing discrete episodes of care, usually binary, rather than long term outcomes for a 
cohort of individuals; this can lead to a focus on the invariant nature of the organisations providing 
the care rather than the varying nature of the individuals receiving care.  These contrasts are 
apparent between, for example: DID studies using panel data to evaluate an intervention such as 
CCT among individuals with CBA studies of an intervention implemented at an organisational level 
studying multiple cross-sections of health care episodes; or credible and less credible interrupted 
time series. 
 
There is a new article in the field of hospital epidemiology which also highlights various features of 
what it terms as quasi-experimental designs [51].  The list of features appear to be aimed at 
researchers designing a quasi-experimental study, acting more as a prompt (e.g. “consider options 
for …”) rather than as a checklist for a researcher appraising a study to communicate clearly to 
others about the nature of a published study, which is our perspective (e.g. a review author). There 
is some overlap with our checklist but the list described also includes several study attributes 
intended to reduce the risk of bias, e.g. blinding. By contrast, we consider an assessment of the risk 
of bias in a study needs to be carried out as a separate task. 
 
Conclusion 
 
The primary intention of the checklist is to help review authors to set eligibility criteria for studies 
to include in a review that relate directly to the intrinsic strength of the studies in inferring causality. 
The checklist should also illuminate the debate between researchers in different fields about the 
strength of studies with different features – a debate which has to date been somewhat obscured by 
the use of different terminology by researchers working in different fields of investigation. 
Furthermore, where disagreements persist, the checklist should allow researchers to inspect the 
basis for these differences, e.g. the principle through which researchers aimed to control for 
confounding, and shift their attention to clarifying the basis for their respective responses for 
particular items. 
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 Table 1: Experimental and quasi-experimental approaches applied in studies evaluating the 
effects of conditional case transfer (CCT) programmes 
 
Study design label Method of analysis CCT programme example 
Randomised 
assignment 
Bivariate (means comparison), 
multivariable regression  
PROGRESSA, Mexico [14] 
Regression 
discontinuity design 
Regression analysis Programme of Advancement 
Through Health and Education 
(PATH), Jamaica [16] 
 Instrumental variables regression 
('fuzzy' discontinuity) 
Bono de Desarrollo Humano 
(BDH), Ecuador [21] 
Natural experiment Instrumental variables (e.g. 2-stage 
least squares) regression analysis 
Bolsa Alimentação, Brazil [23] 
Interrupted time 
series 
Time-series regression analysis Safe Delivery Incentive 
Programme (SDIP), Nepal [24] 
Difference study Difference-in-differences (DID) 
regression analysis 
Familias en Accion, Colombia [25] 
 Triple differences (DDD) 
regression analysis 
Cambodia Education Sector 
Support Project (CESSP) [26] 
Cohort study Propensity score matching (PSM), 
retrospective cohort 
Tekoporã, Paraguay [27] 
Cross-sectional 
study 
Propensity score matching (PSM), 
regression analysis 
Bolsa Familia, Brazil [28] 
 
Sources: reviews of CCTS by Gaarder and colleagues [8], Baird and colleagues [9] and Kabeer and 
Waddington [10]. 
 
 
Table 2 
 
 
RCT Q-RCT IV RD CITS ITS DID CBA NRCT PCS RCS HCT NCC CC XS BA 
1. Was the intervention/comparator: 
(answer “yes” to more than 1 item, if 
applicable)                 
Allocated to (provided for / administered 
to / chosen by) individuals? P P Y Y P P P P P P P P Y Y P P 
Allocated to (provided for / administered 
to / chosen by) clusters of individuals?1 P P N N P P P P P P P P N N P P 
Clustered in the way it was provided (by 
practitioner or organisational unit)?2 P P P P P P P P P P P P P P P P 
                 
2. Were outcome data available: 
(answer “yes” to only 1 item)                 
After intervention / comparator only 
(same individuals)? P P P P N N N N P P P P Y Y Y N 
After intervention / comparator only (not 
all same individuals)? N N N N P P N P P P P P N N N P 
Before (once) AND after intervention / 
comparator (same individuals)? P P P P N N N P P P P P N N P Y 
Before (once) AND after intervention / 
comparator (not all same individuals)? N N N N P P P P P P P P N N N P 
Multiple times before AND multiple 
times after intervention / comparator 
(same individuals)? P P P P P P P P P P P P N N P P 
Multiple times before AND multiple 
times after intervention / comparator (not 
all same individuals)? N N N N P P P P N N N N N N N N 
                 
3. Was the intervention effect 
estimated by:  
(answer “yes” to only 1 item)                 
CHANGE OVER TIME (same 
individuals at different time points)? N N N N N Y N N N N N N N N N P 
CHANGE OVER TIME (not all same 
individuals at different time points)? N N N N N Y N N N N N N N N N P 
 
RCT Q-RCT IV RD CITS ITS DID CBA NRCT PCS RCS HCT NCC CC XS BA 
DIFFERENCE BETWEEN GROUPS3 
(of individuals or clusters receiving 
either intervention or comparator)? Y Y Y Y Y N Y Y Y Y Y Y Y Y Y N 
                 
4. Did the researchers aim to control 
for confounding (design or analysis) 
(answer “yes” to only 1 item): 
                
  Using methods that control in principle 
for any confounding? Y Y Y Y Y Y N N N N N N N N N N 
  Using methods that control in principle 
for time invariant unobserved 
confounding? N N N N N N Y Y N N N N N N N N 
  Using methods that control only for 
confounding by observed covariates? P P P P P P P P Y Y Y Y Y Y Y N 
                 
5. Were groups of individuals or 
clusters formed by (answer “yes” to 
more than 1 item, if applicable):                  
· Randomization? Y N N N N na N N N N N N N N N na 
· Quasi-randomization? N Y N N N na N N N N N N N N N na 
· Explicit rule for allocation based on a 
threshold for a variable measured on a 
continuous or ordinal scale or boundary 
(in conjunction with identifying the 
variable dimension, below)? N N Y Y N na N N N N N N N N N na 
· Some other action of researchers? N N P P P na N N Y P P P N N N na 
· Time differences? N N N N Y na N N N N N Y N N N na 
· Location differences? N N P P P na P P P P P P N N P na 
· Healthcare decision makers / 
practitioners? N N P P P na P P P P P P N N P na 
· Participants’ preferences? N N P N N na P P P P P P N N P na 
· Policy maker N N P P P na P P P P P P N N P na 
· On the basis of outcome?4 N N N N N na N N N N N N Y Y N na 
· Some other process? (specify) N N P P P na P P P P P P N N P na 
 
RCT Q-RCT IV RD CITS ITS DID CBA NRCT PCS RCS HCT NCC CC XS BA 
                 
6. Were the following features of the 
study carried out after the study was 
designed (answer “yes” to more than 1 
item, if applicable):                 
Characterisation of individuals / clusters 
before intervention? Y Y P P P P P P Y Y P P N N N P 
Actions/choices leading to an 
individual/cluster becoming a member of 
a group?4 Y Y P P P na P P Y Y P P N N N na 
Assessment of outcomes? Y Y P P P P P P Y Y P P P P N P 
                 
7. Were the following variables 
measured before intervention:  
(answer “yes” to more than 1 item, if 
applicable):                 
Potential confounders? P P P P P N P P P P P P P P N N 
Outcome variable(s)? P P P P Y Y Y Y P P P P N N N P 
 
Cells in the table are completed with respect to the thumbnail sketches of the corresponding designs described in Boxes 1 and 2. Y=yes; 
N=no; P=possibly, na=not applicable 
 
Footnotes: 
1. This row describes “explicit” clustering. In randomized controlled trials, participants can be allocated individually or by virtue of 
‘belonging’ to a cluster such as a primary care practice or a village. 
2. This row describes “implicit” clustering. In randomized controlled trials, participants can be allocated individually but with the 
intervention being delivered in clusters (e.g. group cognitive therapy); similarly, in a cluster randomized trial (by general practice), an 
intervention could also be clustered provision by therapist, with several therapists providing ‘group’ therapy. 
3. A study should be classified as “yes” for this feature, even if it involves comparing the extent of change over time between groups. 
4. For [nested] case control studies, group refers to the case / control status of an individual. 
5. The distinction between this and practitioner is to do with the exogeneity of the allocation, vis q-RCT versus NE. 
 
 
